Biopsy  Market Trend Analysis: Implications for Growth to 2030

Comments · 59 Views

The advancement of molecular testing is critical to the evolution of the cancer biopsy industry. Biopsies are utilized in clinical studies to evaluate the rates of pharmacological response, particularly in patients receiving EGFR treatment.

Projection of Revenue Growth:

The Biopsy Market size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030).

Biopsy Market Overview

The report offers a thorough overview of the Biopsy Market, detailing market shares, key drivers, restraints, and growth opportunities. It encompasses both international and domestic markets, delivering insights into the landscape, trade dynamics, and significant regions of development.

Details insights on this market, request for methodology here:https://www.maximizemarketresearch.com/request-sample/116684/ 

Biopsy Market Report Scope and Research Methodology

The research for this report delivers a comprehensive analysis of the global Biopsy Market, examining both value and volume aspects and including forecasts for the projected period. It features regional and country-level analyses to identify recent and future growth trends, prospects, and contributions to the market. The report includes essential metrics such as the Compound Annual Growth Rate (CAGR), market size, value, volume, revenue, sales, and other key factors. Each industry segment is evaluated based on its growth rate and market share. Additionally, the report provides an in-depth analysis of key market players by region, covering their revenue, financial status, and technological advancements, thereby offering insights into the competitive landscape. A bottom-up approach is used to accurately estimate the market size.

Biopsy Market Regional Insights

The Biopsy Market is divided into key regions—North America, Europe, Asia Pacific, the Middle East and Africa, and South America—providing a thorough understanding of its global presence and regional impact.

Biopsy Market Segmentation

by Product

Instruments
Kits and Consumables
Services


by Type

Tissue Biopsies
Liquid Biopsies
Others


by Application

Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Liver Cancers
Pancreatic Cancers
Ovarian Cancers
Others

Biopsy Market Key Players

North America
1. Illumina, Inc.(U.S)
2. Quest Diagnostics (U.S)
3. Abbott Laboratories (U.S)
4. GenMark Diagnostics(U.S)
5. Bio-Rad Laboratories (U.S)
6. Agilent Technologies (U.S)
7. Biomarker Technologies (U.S)
8. Coherent, Inc. (U.S)
9. Cardinal Health (U.S)
10. BD (Becton, Dickinson and Company) (U.S)
11. Myriad Genetics (U.S)
12. Hologic, Inc. (U.S)
13. Biocept, Inc. (U.S)
14. Thermo Fisher Scientific, Inc. (U.S)
15. Danaher (U.S)
16. Guardant Health (U.S)
17. Exact Sciences Corporation (U.S)
18. Freenome Holdings, Inc. (U.S)
19. Biodesix (Integrated Diagnostics) (U.S)
20. HelioHealth (Laboratory for Advanced Medicine) (U.S)
21. Genesystems, Inc. (Genesys Biolabs)(U.S)
22. GRAIL, Inc. (U.S)
Europe
1. ANGLE Plc (U.K)
2. Oncimmune (U.K)
3. Epigenomics AG (Germany)
4. Qiagen N.V. (Netherlands)
5. F. Hoffmann-La Roche Ltd. (Switzerland)
Asia Pacific
1. Sysmex Corporation (Japan)
2. Olympus(Japan)
3. Lucence Diagnostics Pte. Ltd. (Singapore)

Please Contact Us On link:https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/ 

Conclusion:

The global Biopsy Market is set to experience significant growth, with projections indicating an increase from USD 32.38 billion in 2023 to USD 67.83 billion by 2030, driven by a robust CAGR of 11.14%. This expansion is fueled by advancements in biopsy technologies, such as the development of liquid biopsies and AI integration, which enhance diagnostic accuracy and patient comfort. North America leads the market due to its advanced healthcare infrastructure and high adoption of innovative biopsy techniques, while the Asia Pacific region is anticipated to grow rapidly, spurred by increased cancer awareness and favorable reimbursement policies. Despite challenges related to high procedure costs, the market's trajectory remains positive, driven by ongoing investments and the rising prevalence of cancer globally.

Explore our top-performing reports on the latest trends:

Global Hypochlorous Acid Market https://www.maximizemarketresearch.com/market-report/global-hypochlorous-acid-market/35187/ 
Global Portable Printer Market https://www.maximizemarketresearch.com/market-report/global-portable-printer-market/28944/ 

About Maximize Market Research: 

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT telecom, chemical, food beverage, aerospace defense, healthcare and others.

Contact Maximize Market Research: 

MAXIMIZE MARKET RESEARCH PVT. LTD.

   ⮝ 3rd Floor, Navale IT park Phase 2,

   Pune Banglore Highway, Narhe

   Pune, Maharashtra 411041, India.

✆ +91 9607365656

 ? sales@maximizemarketresearch.com

? www.maximizemarketresearch.com